Medtronic Receives FDA Warning Letter for Insulin Pump Recall
The warning letter from the FDA is related to recalls of the MiniMed 600 series insulin infusion pump, and a device for MiniMed 508 and Paradigm pumps.
Read MoreDec 15, 2021 | Patient Care Equipment, Recalls | 0 |
The warning letter from the FDA is related to recalls of the MiniMed 600 series insulin infusion pump, and a device for MiniMed 508 and Paradigm pumps.
Read MoreNov 23, 2021 | FDA Updates, Medical Equipment | 0 |
The FDA recognized a non-invasive continuous glucose monitoring system that measures glucose levels in the blood via radiofrequency waves.
Read MoreNov 10, 2021 | Market Trends, Medical Equipment | 0 |
The size of the global home medical equipment market is estimated to reach $56 billion by 2027, according to a report from Allied Market Research.
Read MoreOct 29, 2021 | Medical Equipment, Patient Safety | 0 |
An Atlanta resident died of hypoglycemia after his Dexcom G6 glucose monitoring device failed to sound an alarm; his widow is pursuing a wrongful death suit.
Read MoreThe U.S. FDA has issued a Class I recall on Medtronic’s wireless insulin pump remote controllers. The FDA notified patients of the recall—the most serious type—because of problems with the devices that could cause serious injury or death.
Read More